Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 10—October 2022
About the Cover

A Head of State Leading by Example

Figures
Article Metrics
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (T. Chorba); University of Maryland School of Medicine, Baltimore, Maryland, USA (J. Esparza)

Cite This Article

Timothy Ivanov (1729−1802), Inoculation of Catherine II and Her Son Paul against Smallpox, (c. 1770−1800). Copper, 2.5 in/64.7 mm, 6.1 oz/173 gm. Louvre Museum, Department of Art Objects of the Middle Ages, Renaissance and Modern Times. Permalink: https://collections.louvre.fr/en/ark:/53355/cl010366995

Timothy Ivanov (1729−1802), Inoculation of Catherine II and Her Son Paul against Smallpox, (c. 1770−1800). Copper, 2.5 in/64.7 mm, 6.1 oz/173 gm. Louvre Museum, Department of Art Objects of the Middle Ages, Renaissance and Modern Times. Permalink: https://collections.louvre.fr/en/ark:/53355/cl010366995

Before the introduction of smallpox vaccine, variolation was practiced as a preventive measure (i.e., deliberate infection with smallpox to provide immunity), most commonly by inserting or rubbing material from smallpox lesions into the skin of uninfected persons. Most persons thus infected would get a milder case of smallpox as the virus was generally introduced via the skin rather than via the respiratory route, as is the case of natural exposure. Infection occurring in this manner could still be transmitted by droplets to others who could develop a full-blown case of smallpox. Variolation developed over several centuries in many different sites including China, India, Sudan, Asia Minor, and Britain. Because variolation was reputed to have risk of inducing severe disease, variolation hesitancy existed long before the smallpox vaccine and its associated vaccine hesitancy. Inoculation with materials putatively derived from cowpox lesions (vaccination) or from horsepox lesions (equination) was a welcomed advance because it was safer and did not present the hazard of onward transmission of smallpox to the contacts of recipients.

Figure

Obverse of medal featured on the cover art. Timothy Ivanov (1729−1802), Bust of Catherine II, (c. 1770−1800). Copper, 2.5 in/64.7 mm, 6.1 oz/173 gm. Louvre Museum, Department of Art Objects of the Middle Ages, Renaissance and Modern Times. Permalink: https://collections.louvre.fr/en/ark:/53355/cl010366995

Figure. Obverse of medal featured on the cover art. Timothy Ivanov (1729−1802), Bust of Catherine II, (c. 1770−1800). Copper, 2.5 in/64.7 mm, 6.1 oz/173 gm. Louvre Museum,...

On the cover of this month’s journal is an image of a copper medal, executed by the Russian sculptor Timothy Ivanov (1729‒1802). Ivanov created several medals celebrating the contributions of Catherine II (1729–1796), also known as Catherine the Great, whose reign (1762‒1796) was that of Russia’s longest-ruling female leader. This medal was struck to honor those most distinguished in Russia’s mass immunization efforts against smallpox at the turn of the 18th into the 19th centuries. On the obverse (Figure), a crowned right-facing bust of Catherine is surrounded by a legend that reads Б[ОЖИЕЮ] ∙ М[ИЛОСТЬЮ] ∙ ЕКАТЕРИНА II ИМПЕРАТ[РИЦА] ∙ И САМОДЕРЖ[ИЦА] ∙ ВСЕРОСС[ИЙСКАЯ] (By the grace of God, Catherine II, Empress and absolute ruler of all Russia). Underneath the bust is inscribed TИМOΘЕИ. ÏВАН[ОВЬ] (Timothy Ivan[ov]). On the reverse (featured on the cover) is a female figure, presumably Catherine herself, holding the hand of her son, Paul Petrovich (later Tsar Paul I), encountering another female figure, perhaps Russia itself, and two small children. Representing disease, a dead hydra lies in the background below the colonnade and pediment of a classical-style building; these figures are surrounded by a legend: COБOЮ ПOДАΛА ПPИМҌPЪ (She herself set the example). Beneath is the Russian lettering for “October 12 in the year 1768,” the date on which Catherine was inoculated with smallpox material.

Catherine’s efforts focused on the high endemicity of smallpox in Russia after the death of one of her ministers and after corresponding with Voltaire, another proponent of variolation. In 1768, Catherine recruited Thomas Dimsdale, an English physician who had published on inoculation methods and on variolation. On October 12, the empress was variolated in great secrecy. She then developed a mild case of smallpox, from which she recovered in 2 weeks. Her son, Paul, was variolated with material from one of her own smallpox pustules. However, as a precaution, in case her subjects were to hold Dimsdale accountable if she were to become gravely ill or die after variolation, Catherine had arranged for a yacht to be stationed temporarily in the Gulf of Finland to convey Dimsdale to a site out of danger, if needed. News of the success of Catherine’s procedure was then widely disseminated and Dimsdale inoculated more than 140 members of her court. The response to Catherine’s successful experiment was widespread uptake of the procedure elsewhere in Russia, and a burst of interest in funding hospitals and training programs and improving healthcare in general.

The use of medals as a decorative form of jewelry dates to the 4th century bce, but from the Renaissance into the 19th century, the portrait medal flourished as a distinct art form to honor public figures. Medals have also been commonly used to commemorate public events or to reward worthy individuals. More than 20,000 medals are in the domain of medical numismatics, many of which commemorate discoveries in infectious diseases and the ends of epidemics. What sets Catherine’s medal apart is its uniqueness as a tool of public health advocacy.

In 1796, English physician Edward Jenner inoculated a child with fluid extracted from human cowpox lesions. After the same child was later inoculated with material obtained from a human smallpox lesion, the child exhibited no clinical symptoms of smallpox, demonstrating that receipt of cowpox inoculation was protective against smallpox. The procedure was successful because cowpox virus and smallpox virus both belong to the same family (Poxviridae) and genus (Orthopoxvirus) of viruses; some Orthopoxvirus species generate cross-immunity in humans against subsequent infection with certain other Orthopoxvirus species. Another example of cross-immunity was observed after monkeypox, another Orthopoxvirus species, was identified in human populations. In the 1980s, when greater numbers of persons in Zaire (now the Democratic Republic of the Congo) had received smallpox vaccine, its prior receipt was found to confer considerable protection in close contacts of persons with monkeypox and in reducing the severity of disease associated with monkeypox. This phenomenon has been noted in considerations of vaccine development and risk in the current monkeypox outbreak.

The work of Dimsdale in pursuing variolation, the work of Catherine II in mobilizing the support of influential nobles to overcome inoculation hesitancy, and the work of Jenner in developing the first vaccine against smallpox all took place many decades before the germ theory of disease was conceived of and demonstrated by Edwin Klebs, Louis Pasteur, Robert Koch, and their disciples. As public recognition of the science and its success increased, variolation was replaced by the less risky practice of vaccination and inoculation hesitancy decreased with the concomitant decrease in associated adverse events. 

Top

Bibliography

  1. Boylston  A. The origins of inoculation. J R Soc Med. 2012;105:30913. DOIPubMedGoogle Scholar
  2. Clendenning  PH. Dr. Thomas Dimsdale and smallpox inoculation in Russia. J Hist Med Allied Sci. 1973;28:10925. DOIPubMedGoogle Scholar
  3. Damon  IK. Poxviruses. In: Knipe DM, Howley PM, editors. Fields virology. 6th ed. Philadelphia: Lippincott, Williams & Wilkins; 2013. p. 2160–84.
  4. Esparza  J. Early vaccine advocacy: Medals honoring Edward Jenner issued during the 19th century. Vaccine. 2020;38:14506. DOIPubMedGoogle Scholar
  5. Esparza  J, Schrick  L, Damaso  CR, Nitsche  A. Equination (inoculation of horsepox): An early alternative to vaccination (inoculation of cowpox) and the potential role of horsepox virus in the origin of the smallpox vaccine. Vaccine. 2017;35:722230. DOIPubMedGoogle Scholar
  6. Fine  PE, Jezek  Z, Grab  B, Dixon  H. The transmission potential of monkeypox virus in human populations. Int J Epidemiol. 1988;17:64350. DOIPubMedGoogle Scholar
  7. Griffiths  J. Doctor Thomas Dimsdale, and smallpox in Russia. The variolation of the Empress Catherine the Great. Bristol Med Chir J. 1984;99:146.PubMedGoogle Scholar
  8. Proskurina, V. Creating the empress: politics and poetry in the age of Catherine II. Boston: Academic Studies Press; 2011. p. 89 [cited 2022 Aug 2]. https://www.academicstudiespress.com/arsrossica/creating-the-empress-politics-and-poetry-in-the-age-of-catherine-ii
  9. Razzell  P. The conquest of smallpox. London: Caliban; 1977.
  10. Ward  L. The empress and the English doctor: how Catherine the Great defied a deadly virus. London: Oneworld Publications; 2022.
  11. Williams  G. Angel of death. Basingstoke (UK): Palgrave Macmillan, 2010.

Top

Figure

Top

Cite This Article

DOI: 10.3201/eid2810.ac2810

Original Publication Date: September 21, 2022

Related Links

Top

Table of Contents – Volume 28, Number 10—October 2022

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.

Top

Comments

Please use the form below to submit correspondence to the authors or contact them at the following address:

Terence Chorba, Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mailstop US12-4, Atlanta, GA 30329-4027, USA

Send To

10000 character(s) remaining.

Top

Page created: September 21, 2022
Page updated: October 04, 2022
Page reviewed: October 04, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external